## Abstract The objective of this study was to determine effect sizes for both antidepressant treatment and placebo for depression in Parkinson's disease (PD), and to compare the findings with those reported in elderly depressed patients without PD. Recent reviews have concluded that there is littl
A meta-analysis of six prospective studies of falling in Parkinson's disease
β Scribed by Ruth M. Pickering; Yvette A.M. Grimbergen; Una Rigney; Ann Ashburn; Gordon Mazibrada; Brian Wood; Peggy Gray; Graham Kerr; Bastiaan R. Bloem
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 155 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Recurrent falls are a disabling feature of Parkinson's disease (PD). We have estimated the incidence of falling over a prospective 3 month followβup from a large sample size, identified predictors for falling for PD patients repeated this analysis for patients without prior falls, and examined the risk of falling with increasing disease severity. We pooled six prospective studies of falling in PD (n = 473), and examined the predictive power of variables that were common to most studies. The 3βmonth fall rate was 46% (95% confidence interval: 38β54%). Interestingly, even among subjects without prior falls, this fall rate was 21% (12β35%). The best predictor of falling was two or more falls in the previous year (sensitivity 68%; specificity 81%). The risk of falling rose as UPDRS increased, to about a 60% chance of falling for UPDRS values 25 to 35, but remained at this level thereafter with a tendency to taper off towards later disease stages. These results confirm the high frequency of falling in PD, as almost 50% of patients fell during a short period of only 3 months. The strongest predictor of falling was prior falls in the preceding year, but even subjects without any prior falls had a considerable risk of sustaining future falls. Disease severity was not a good predictor of falls, possibly due to the complex Uβshaped relation with falls. Early identification of the very first fall therefore remains difficult, and new prediction methods must be developed. Β© 2007 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract We sought to determine the relative risk (RR) of Parkinson's disease (PD) for having a firstβdegree relative with PD versus having no firstβdegree relative with PD. Studies of familial aggregation of PD were identified by searching Medline and other sources. From each study, RRs were ex
## Abstract Few prospective data on the clinical progression of Parkinson's disease (PD) in patient groups outside treatment trials in selected patients are available, and controversy exists on the rate of clinical disease progression with advancing disease. In this study, we investigated the rate
## Abstract Twentyβtwo patients with Parkinson's disease drawn from a communityβbased study were followed prospectively until their deaths. Even though 18 patients had dementia, none fulfilled Braak and Braak or The National Institute on Aging and Ronald and Nancy Reagan Institute of the Alzheimer'
## Abstract We estimated the pooled risk of tobacco smoking for Parkinson's disease (PD). Inclusion criteria included systematic searches of MedLine, PsycLIT, Embase, Current Contents, previously published reviews, examination of cited reference sources, and personal contact and discussion with sev